PE20061311A1 - Forma cristalina ortorrombica del maleato de asenapina en el tratamiento de esquizofrenia - Google Patents
Forma cristalina ortorrombica del maleato de asenapina en el tratamiento de esquizofreniaInfo
- Publication number
- PE20061311A1 PE20061311A1 PE2006000377A PE2006000377A PE20061311A1 PE 20061311 A1 PE20061311 A1 PE 20061311A1 PE 2006000377 A PE2006000377 A PE 2006000377A PE 2006000377 A PE2006000377 A PE 2006000377A PE 20061311 A1 PE20061311 A1 PE 20061311A1
- Authority
- PE
- Peru
- Prior art keywords
- schizophrenia
- treatment
- compound
- orthorrhombic
- crystal form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE (Z)-2-BUTENODIATO DE TRANS-5-CLORO-2,3,3a,12b-TETRAHIDRO-2-METIL-1H-DIBENZ[2,3:6,7]OXEPINO[4,5-c]PIRROL EN FORMA CRISTALINA ORTORROMBICA CARACTERIZADO POR UN PATRON DE DIFRACCION DE RAYOS X DE POLVO OBTENIDO CON RADIACION CuKALFA CON PICOS DE VALORES DE 2 TETHA DE 10,5; 15,7 Y UN PATRON ESPECTROSCOPICO RAMAN CON PICOS A VALORES DE 2.888 cm-1, 824 cm-1. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION QUE COMPRENDE EN CRISTALIZAR EL COMPUESTO A PARTIR DE UNA MEZCLA DE ETANOL/AGUA EN UNA PROPORCION EN VOLUMEN DE 9:1. EL COMPUESTO DE LA INVENCION ES UTIL EN EL TRATAMIENTO DE ESQUIZOFRENIA O TRASTORNO BIPOLAR
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05102742 | 2005-04-07 | ||
| EP05102969 | 2005-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061311A1 true PE20061311A1 (es) | 2007-02-09 |
Family
ID=36617328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000377A PE20061311A1 (es) | 2005-04-07 | 2006-04-06 | Forma cristalina ortorrombica del maleato de asenapina en el tratamiento de esquizofrenia |
Country Status (31)
| Country | Link |
|---|---|
| EP (2) | EP1710245B1 (es) |
| JP (1) | JP5058151B2 (es) |
| KR (1) | KR101422843B1 (es) |
| AR (1) | AR056306A1 (es) |
| AT (2) | ATE418556T1 (es) |
| AU (1) | AU2006231617B2 (es) |
| BR (1) | BRPI0609741A8 (es) |
| CA (1) | CA2603509C (es) |
| CY (2) | CY1106902T1 (es) |
| DE (2) | DE602006000080T2 (es) |
| DK (2) | DK1710245T3 (es) |
| DO (1) | DOP2006000082A (es) |
| ES (2) | ES2318742T3 (es) |
| GT (1) | GT200600135A (es) |
| HN (1) | HN2006014095A (es) |
| HR (1) | HRP20070429T3 (es) |
| IL (1) | IL186355A (es) |
| MX (1) | MX2007012445A (es) |
| MY (1) | MY137969A (es) |
| NO (1) | NO340520B1 (es) |
| NZ (1) | NZ562124A (es) |
| PE (1) | PE20061311A1 (es) |
| PL (2) | PL1917267T3 (es) |
| PT (2) | PT1917267E (es) |
| RS (1) | RS50532B (es) |
| RU (1) | RU2405786C2 (es) |
| SI (2) | SI1710245T1 (es) |
| SV (1) | SV2006002473A (es) |
| TW (1) | TWI364423B (es) |
| UY (1) | UY29459A1 (es) |
| WO (1) | WO2006106135A1 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200831514A (en) * | 2006-10-06 | 2008-08-01 | Organon Nv | Amorphous asenapine and processes for preparing same |
| US8658687B2 (en) * | 2009-06-24 | 2014-02-25 | Merck Sharp & Dohme Corp. | Injectable formulations containing asenapine and method of treatment using same |
| US8779161B2 (en) | 2010-06-18 | 2014-07-15 | Dr. Reddy's Laboratories Limited | Asenapine maleate |
| WO2012066565A2 (en) * | 2010-11-16 | 2012-05-24 | Cadila Healthcare Limited | Asenapine maleate amorphous and crystalline form and process for preparation thereof |
| EP2468750A1 (en) | 2010-12-13 | 2012-06-27 | Chemo Ibérica, S.A. | Polymorphic forms of asenapine maleate and processes for their preparation |
| WO2012123325A1 (en) | 2011-03-11 | 2012-09-20 | Medichem S.A. | NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID |
| ITMI20110734A1 (it) * | 2011-05-02 | 2012-11-03 | Olon Spa | Sali cristallini di asenapina |
| EP2524920A1 (en) | 2011-05-17 | 2012-11-21 | Sandoz AG | Novel Crystalline Asenapine Hydrochloride Salt Forms |
| EP2524919A1 (en) | 2011-05-17 | 2012-11-21 | Sandoz AG | Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids |
| EP2524921A1 (en) | 2011-05-17 | 2012-11-21 | Sandoz AG | Novel Crystalline Salts of Asenapine |
| JP6014656B2 (ja) * | 2011-05-18 | 2016-10-25 | ラビラトリオス レスビ エス エレ | 化合物の多形体 |
| US9533994B2 (en) | 2011-05-18 | 2017-01-03 | Laboratorios Lesvi S.L. | Monoclinic crystalline form of asenapine maleate with a specific particle size distribution |
| EP2572703A1 (en) | 2011-09-21 | 2013-03-27 | Hexal AG | Compressed oral dosage form for asenapine maleate |
| WO2013041604A1 (en) | 2011-09-21 | 2013-03-28 | Sandoz Ag | Crystal form of asenapine maleate |
| TWI603748B (zh) * | 2012-07-26 | 2017-11-01 | 久光製藥股份有限公司 | Adhesive |
| ITMI20121810A1 (it) | 2012-10-24 | 2014-04-25 | Chemo Iberica Sa | Poliformi di maleato di asenapina e processo per la loro preparazione |
| US9597291B2 (en) | 2012-12-11 | 2017-03-21 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Orally disintegrating tablet containing asenapine |
| WO2014127786A1 (en) | 2013-02-22 | 2014-08-28 | Zentiva, K.S. | Orally disintegrating pharmaceutical composition comprising asenapine |
| US10786520B2 (en) | 2015-09-02 | 2020-09-29 | Eloxx Pharmaceuticals Ltd. | Aminoglycoside derivatives and uses thereof in treating genetic disorders |
| EP3558276A1 (en) | 2016-12-20 | 2019-10-30 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| CN115813888A (zh) | 2016-12-20 | 2023-03-21 | 罗曼治疗系统股份公司 | 包含阿塞那平的透皮治疗系统 |
| JP2020525545A (ja) | 2017-06-26 | 2020-08-27 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム |
| MX2020014286A (es) | 2018-06-20 | 2021-03-25 | Lts Lohmann Therapie Systeme Ag | Sistema terapeutico transdermico que contiene asenapina. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
| RU2139051C1 (ru) * | 1994-03-02 | 1999-10-10 | Акцо Нобель Н.В. | Сублингвальная или трансбуккальная фармацевтическая композиция |
| WO1999032108A1 (en) * | 1997-12-19 | 1999-07-01 | Akzo Nobel N.V. | Org-5222 in the treatment of depression |
| TWI327915B (en) * | 2003-06-12 | 2010-08-01 | Organon Nv | Pharmaceutical composition comprising antipsychotic agent and use of the antipsychotic agent for treating patients with overweight |
-
2006
- 2006-04-06 RU RU2007141198/04A patent/RU2405786C2/ru active Protection Beyond IP Right Term
- 2006-04-06 DE DE602006000080T patent/DE602006000080T2/de active Active
- 2006-04-06 CA CA2603509A patent/CA2603509C/en active Active
- 2006-04-06 MY MYPI20061554A patent/MY137969A/en unknown
- 2006-04-06 AU AU2006231617A patent/AU2006231617B2/en active Active
- 2006-04-06 UY UY29459A patent/UY29459A1/es not_active Application Discontinuation
- 2006-04-06 RS RSP-2007/0436A patent/RS50532B/sr unknown
- 2006-04-06 SI SI200630006T patent/SI1710245T1/sl unknown
- 2006-04-06 ES ES06725622T patent/ES2318742T3/es active Active
- 2006-04-06 AT AT06725622T patent/ATE418556T1/de active
- 2006-04-06 DK DK06112332T patent/DK1710245T3/da active
- 2006-04-06 PT PT06725622T patent/PT1917267E/pt unknown
- 2006-04-06 WO PCT/EP2006/061408 patent/WO2006106135A1/en active Application Filing
- 2006-04-06 JP JP2008504776A patent/JP5058151B2/ja active Active
- 2006-04-06 NZ NZ562124A patent/NZ562124A/en unknown
- 2006-04-06 MX MX2007012445A patent/MX2007012445A/es active IP Right Grant
- 2006-04-06 DO DO2006P000082A patent/DOP2006000082A/es unknown
- 2006-04-06 PL PL06725622T patent/PL1917267T3/pl unknown
- 2006-04-06 TW TW095112187A patent/TWI364423B/zh active
- 2006-04-06 AR ARP060101358A patent/AR056306A1/es not_active Application Discontinuation
- 2006-04-06 GT GT200600135A patent/GT200600135A/es unknown
- 2006-04-06 KR KR1020077025428A patent/KR101422843B1/ko active IP Right Grant
- 2006-04-06 BR BRPI0609741A patent/BRPI0609741A8/pt not_active IP Right Cessation
- 2006-04-06 SI SI200630190T patent/SI1917267T1/sl unknown
- 2006-04-06 EP EP06112332A patent/EP1710245B1/en active Active
- 2006-04-06 DE DE602006004463T patent/DE602006004463D1/de active Active
- 2006-04-06 AT AT06112332T patent/ATE370954T1/de active
- 2006-04-06 ES ES06112332T patent/ES2293626T3/es active Active
- 2006-04-06 PE PE2006000377A patent/PE20061311A1/es active IP Right Grant
- 2006-04-06 SV SV2006002473A patent/SV2006002473A/es unknown
- 2006-04-06 HN HN2006014095A patent/HN2006014095A/es unknown
- 2006-04-06 EP EP06725622A patent/EP1917267B1/en active Active
- 2006-04-06 DK DK06725622T patent/DK1917267T3/da active
- 2006-04-06 PT PT06112332T patent/PT1710245E/pt unknown
- 2006-04-06 PL PL06112332T patent/PL1710245T3/pl unknown
-
2007
- 2007-09-19 HR HR20070429T patent/HRP20070429T3/xx unknown
- 2007-10-02 CY CY20071101258T patent/CY1106902T1/el unknown
- 2007-10-07 IL IL186355A patent/IL186355A/en active IP Right Grant
- 2007-10-10 NO NO20075142A patent/NO340520B1/no unknown
-
2009
- 2009-01-30 CY CY20091100111T patent/CY1108742T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20061311A1 (es) | Forma cristalina ortorrombica del maleato de asenapina en el tratamiento de esquizofrenia | |
| UA93044C2 (en) | urn:schemas-microsoft-com:office:smarttagsCRYSTALFORM OF ASENAPINE MALEATE | |
| NO20054404L (no) | 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon | |
| PE20110568A1 (es) | Agentes terapeuticos 414 | |
| ECSP055964A (es) | Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6 | |
| TW200740787A (en) | (6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones | |
| EP2040712A4 (en) | PRODRUGS WITH FUNCTIONAL GROUPS CARBONATE AND CARBAMATE OF THIAZOLO [4,5-D] PYRIMIDINES | |
| CA2793138C (en) | Hydroxybenzoate salts of metanicotine compounds | |
| PE20060947A1 (es) | Forma cristalina (ii) de n-benzoil-estaurosporina y procedimiento para su preparacion | |
| WO2007064842A3 (en) | Synthesis of chlorins and phorbines with enhanced red spectral features | |
| PE20091970A1 (es) | Nueva sal 554 | |
| HK1110211A1 (es) | ||
| NO20074009L (no) | Alkoholholdig drikkevare anriket med lH2 16O | |
| NO20073440L (no) | Prosess for fremstilling av candesartan | |
| PE20070456A1 (es) | Sales salicilato y gentisato del compuesto 8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona | |
| USD532158S1 (en) | Monkey bath puff | |
| IL185015A0 (en) | New synthesis of a camptothecin subunit | |
| PE20020829A1 (es) | Derivados del biciclo[3.1.0]hexano | |
| WO2007147480A3 (en) | Polymorphic forms and process | |
| UA80871C2 (en) | 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension | |
| ITRM20010318A0 (it) | Procedimento per la produzione di composti organici perfluorurati mediante florurazione elettrochimica. | |
| NO20063686L (no) | Anvendelse av o-ATP for behandling av sykdommer omfattende angiogenese | |
| WO2005097089A3 (en) | Derivatives of leinamycin for use as anticancer agents | |
| TH76785B (th) | สารประกอบลาพาโคนชนิดใหม่และวิธีใช้มัน | |
| TH76785A (th) | สารประกอบลาพาโคนชนิดใหม่และวิธีใช้มัน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |